Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Nova Ltd banner

Nova Ltd
SWB:NMR

Watchlist Manager
Nova Ltd Logo
Nova Ltd
SWB:NMR
Watchlist
Price: 335.1 EUR -7.76% Market Closed
Market Cap: €9.6B
Write Note Create Alert Ask AI

Wall St Price Targets

NMR Price Targets Summary
Nova Ltd

Wall Street analysts forecast NMR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NMR is 531.77 EUR with a low forecast of 471.87 EUR and a high forecast of 581.4 EUR.

NMR Lowest Forecast
Wall Street Target
€471.87
41% Upside
NMR Average Forecast
Wall Street Target
€531.77
59% Upside
NMR Highest Forecast
Wall Street Target
€581.4
73% Upside
Lowest Forecast
Price Target
471.87 EUR
41% Upside
Average Forecast
Price Target
531.77 EUR
59% Upside
Highest Forecast
Price Target
581.4 EUR
73% Upside
Nova Ltd Competitors:
Price Targets
IONS
Ionis Pharmaceuticals Inc
46% Upside
NWPX
Northwest Pipe Co
3% Upside
IONS
Ionis Pharmaceuticals Inc
46% Upside
NWPX
Northwest Pipe Co
3% Upside

Revenue
Forecast

31% / Year
Past Growth
17% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
31% / Year
Past Growth
17% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 1 year, the compound annual growth rate for Revenue has been 31%. The projected CAGR for the next 5 years is 17%.

What are analyst estimates?

Gross Profit
Forecast

31% / Year
Past Growth
19% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
31% / Year
Past Growth
19% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 1 year, the compound annual growth rate for Gross Profit has been 31%. The projected CAGR for the next 5 years is 19%.

What are analyst estimates?

Operating Income
Forecast

35% / Year
Past Growth
24% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
35% / Year
Past Growth
24% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 1 year, the compound annual growth rate for Operating Income has been 35%. The projected CAGR for the next 5 years is 24%.

What are analyst estimates?

Pre-Tax Income
Forecast

40% / Year
Past Growth
24% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
40% / Year
Past Growth
24% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 1 year, the compound annual growth rate for Pre-Tax Income has been 40%. The projected CAGR for the next 3 years is 24%.

What are analyst estimates?

Net Income
Forecast

41% / Year
Past Growth
20% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
41% / Year
Past Growth
20% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 1 year, the compound annual growth rate for Net Income has been 41%. The projected CAGR for the next 5 years is 20%.

What are analyst estimates?

Continue NMR Research

Summary
NMR intrinsic value, competitors valuation, and company profile.
DCF Valuation
NMR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NMR stock valuation using valuation multiples.
Wall St Estimates
NMR price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NMR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Nova Ltd listings:
F • EUR
NMR
 XBER • EUR
NMR
 NASDAQ • USD
NVMI
 TASE • ILS
NVMI
 LSE • ILS
0YAA
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is NMR's stock price target?
Price Target
531.77 EUR

According to Wall Street analysts, the average 1-year price target for NMR is 531.77 EUR with a low forecast of 471.87 EUR and a high forecast of 581.4 EUR.

What is the Revenue forecast for Nova Ltd?
Projected CAGR
17%

Over the last 1 year, the compound annual growth rate for Revenue has been 31%. The projected CAGR for the next 5 years is 17%.

What is the Gross Profit forecast for Nova Ltd?
Projected CAGR
19%

Over the last 1 year, the compound annual growth rate for Gross Profit has been 31%. The projected CAGR for the next 5 years is 19%.

What is the Operating Income forecast for Nova Ltd?
Projected CAGR
24%

Over the last 1 year, the compound annual growth rate for Operating Income has been 35%. The projected CAGR for the next 5 years is 24%.

What is the Pre-Tax Income forecast for Nova Ltd?
Projected CAGR
24%

Over the last 1 year, the compound annual growth rate for Pre-Tax Income has been 40%. The projected CAGR for the next 3 years is 24%.

What is the Net Income forecast for Nova Ltd?
Projected CAGR
20%

Over the last 1 year, the compound annual growth rate for Net Income has been 41%. The projected CAGR for the next 5 years is 20%.

Back to Top
ALPHA SPREAD
Follow us
Join 353,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett